Jove
Visualize
Contact Us

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Types of Signaling Molecules01:32

Types of Signaling Molecules

10.1K
In multicellular organisms, many molecules transmit signals between cells to pass information. These signals vary in complexity and include small peptides, nucleotides, steroids, fatty acid derivatives, and dissolved gases such as nitric oxide. Some signaling molecules diffuse through the plasma membrane to act locally between neighboring cells or travel long distances. Others remain attached to the cell surface, transmitting information to other cells only when they make contact. In some...
10.1K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SCANDARE: an institutional dynamic prospective interventional biobanking study.

BMC cancer·2026
Same author

PROCA11 early activation fuels prostate cancer neuroendocrine traits by regulating cell survival and migration.

iScience·2025
Same author

Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment.

NAR cancer·2025
Same author

The role of nonsense-mediated mRNA decay in restricting long noncoding RNA expression has been conserved in RNAi-capable budding yeast.

RNA (New York, N.Y.)·2025
Same author

Intergenic accumulation of RNA polymerase II maintains the potential for swift transcriptional restart upon release from quiescence.

Genome research·2025
Same author

Oncogenic and teratogenic effects of <i>Trp53</i><sup>Y217C</sup>, an inflammation-prone mouse model of the human hotspot mutant <i>TP53</i><sup>Y220C</sup>.

eLife·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 6, 2025

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
10:33

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

1.2K

Extracellular Vesicle lncRNAs as Key Biomolecules for Cell-to-Cell Communication and Circulating Cancer Biomarkers.

Panagiotis Papoutsoglou1, Antonin Morillon1

  • 1ncRNA, Epigenetics and Genome Fluidity, CNRS UMR3244, Sorbonne Université, PSL University, Institut Curie, Centre de Recherche, F-75248 Paris, France.

Non-Coding RNA
|November 25, 2024
PubMed
Summary

Extracellular vesicles (EVs) carry biomolecules that reprogram cells. Their non-coding RNA cargo is crucial for cancer progression and shows potential as cancer biomarkers.

Keywords:
biomarkersextracellular vesiclesnon-coding RNAtumorigenesis

More Related Videos

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
12:18

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

Published on: February 1, 2020

5.7K
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.5K

Related Experiment Videos

Last Updated: Jun 6, 2025

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
10:33

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

1.2K
LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
12:18

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

Published on: February 1, 2020

5.7K
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.5K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Extracellular vesicles (EVs) are cell-secreted nanoparticles containing biomolecules like RNA.
  • EVs mediate intercellular communication, influencing recipient cell function.
  • The role of specific EV biomolecules versus total cargo in cellular effects is debated.

Purpose of the Study:

  • To review the functional roles of EV non-coding RNA in cancer progression.
  • To highlight EV RNA as potential cancer diagnostic and prognostic biomarkers.
  • To discuss technological challenges in EV RNA analysis.

Main Methods:

  • Literature review focusing on extracellular vesicles and non-coding RNA.
  • Analysis of studies on EV RNA in cancer biology and diagnostics.
  • Evaluation of current technologies for EV RNA detection and preservation.

Main Results:

  • EV non-coding RNAs play significant roles in cancer development and progression.
  • EV RNA profiles show promise as sensitive biomarkers for cancer detection and prognosis.
  • Technological limitations currently hinder widespread clinical application of EV RNA analysis.

Conclusions:

  • EV non-coding RNAs are key mediators of cancer progression.
  • EV RNA holds significant potential for non-invasive cancer diagnostics and prognostics.
  • Advancements in technology are needed to fully realize the clinical utility of EV RNA biomarkers.